Barinthus Biotherapeutics plc (BRNS)

NASDAQ: BRNS · IEX Real-Time Price · USD

1.940

-0.030 (-1.52%)

At close: May 31, 2024, 3:58 PM

1.970

+0.030 (1.55%)

After-hours: May 31, 2024, 7:25 PM EDT

Barinthus Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	74	142	88	387	-	-
Market Cap Growth	-	62.36%	-77.36%	-	-	-
Enterprise Value	-43	13	-98	180	3	-10
PE Ratio	-1.31	-1.94	16.41	-7.61	-	-
PS Ratio	222.75	177.44	1.96	1444.82	-	-
PB Ratio	0.43	0.76	0.36	1.54	-	-
P/FCF Ratio	-1.48	-2.53	-4.34	-11.48	-	-
P/OCF Ratio	-1.55	-2.79	-6.07	-11.88	-	-
EV/Sales Ratio	-73.45	16.45	-2.19	673.05	0.64	-1.41
EV/EBITDA Ratio	0.37	-0.19	-15.24	-3.81	-0.22	0.48
EV/EBIT Ratio	0.33	-0.17	-110.07	-3.74	-0.22	0.47
EV/FCF Ratio	0.39	-0.23	4.85	-5.35	-0.27	0.51
Debt / Equity Ratio	0.07	0.07	0.04	0.03	-1.26	-0.08
Debt / EBITDA Ratio	-0.19	-0.19	1.36	-0.15	-3.36	-0.09
Debt / FCF Ratio	-0.20	-0.23	-0.43	-0.21	-4.10	-0.09
Quick Ratio	10.13	11.28	16.36	19.19	5.73	2.16
Current Ratio	11.15	12.46	17.40	20.32	6.27	2.83
Asset Turnover	0.00	0.00	0.16	0.00	0.14	-
Interest Coverage	-1831.85	-2728.36	46.84	-18.08	-3.89	-155.16
Return on Equity (ROE)	-36.70%	-37.30%	2.10%	-29.40%	59.70%	-
Return on Assets (ROA)	-31.80%	-32.40%	1.90%	-21.10%	-50.80%	-
Return on Capital (ROIC)	-42.97%	-42.01%	-9.85%	-17.44%	-212.08%	124.17%
Earnings Yield	-95.05%	-51.54%	6.09%	-13.14%	-	-
FCF Yield	-84.39%	-39.59%	-23.03%	-8.71%	-	-
Buyback Yield / Dilution	-2.00%	-0.57%	-47.40%	-227.59%	66.32%	-
Total Shareholder Return	-2.00%	-0.57%	-47.40%	-227.59%	66.32%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).